Literature DB >> 5684188

Persistent hyperemia following prolonged arterial occlusion.

D S Sumner, R Folse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5684188      PMCID: PMC1387376          DOI: 10.1097/00000658-196811000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  6 in total

1.  REACTIVE HYPEREMIA IN HUMAN EXTREMITIES.

Authors:  J T SHEPHERD
Journal:  Circ Res       Date:  1964-08       Impact factor: 17.367

2.  HEPATIC SURGERY: TRAUMA, TUMORS AND CYSTS.

Authors:  W P LONGMIRE
Journal:  Ann Surg       Date:  1965-01       Impact factor: 12.969

3.  The hyperemia of reconstructive arterial surgery.

Authors:  F A SIMEONE; E A HUSNI
Journal:  Ann Surg       Date:  1959-10       Impact factor: 12.969

4.  The rate of blood flow in the foot and calf before and after reconstruction by arterial grafting of an occluded main artery to the lower limb.

Authors:  P GASKELL
Journal:  Clin Sci       Date:  1956-05       Impact factor: 6.124

5.  The measurement of volume changes in human limbs.

Authors:  R J WHITNEY
Journal:  J Physiol       Date:  1953-07       Impact factor: 5.182

6.  Hyperaemia of the calf after arterial reconstruction for atherosclerotic occlusion. A plethysmographic study.

Authors:  J L Wellington; V Olszewski; P Martin
Journal:  Br J Surg       Date:  1966-03       Impact factor: 6.939

  6 in total
  2 in total

1.  Local regulation of blood flow and the occurrence of edema after arterial reconstruction of the lower limbs.

Authors:  J H Eickhoff; H C Engell
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

2.  Prospective randomized controlled trial to analyze the effects of intermittent pneumatic compression on edema following autologous femoropopliteal bypass surgery.

Authors:  Alexander te Slaa; Dennis E J G J Dolmans; Gwan H Ho; Paul G H Mulder; Jan C H van der Waal; Hans G W de Groot; Lijckle van der Laan
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.